Impact of antibiotic treatment regimen on sexual behaviour following urogenital Chlamydia trachomatis infectio

Not Applicable

Withdrawn

• Conditions: Chlamydia trachomatis; Infection - Sexually transmitted infections

• Registration Number: ACTRN12616001584426
• Lead Sponsor: niversity of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Heterosexual patients diagnosed positive for asymptomatic urogential chlamydia by nucleic acid amplification test.

Adequate English and comprehension skills to give consent

Willing and able to answer to survey questions by SMS.

Exclusion Criteria

Patients will be excluced if they are:
they are concurrently diagnosed with another bacterial STI;
have known contraindications to trial medications;
present with symptomatic urethritis or pelvic inflammatory disease;
are currently engaged in commercial sex work;
or are pregnant.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome will be sexual intercourse in the last 24 hours- yes/no with sexual intercourse defined as penile/vaginal insertion.<br><br>Although the definition for sexual intercourse is very broad, the study will be limited to urogenital infection among heterosexuals.<br><br>Starting 24 hours since starting treatment, participants will be sent daily short message service (SMS) that ask the following question: In the last 24 hours, did you have any sexual intercourse? Yes/No for 1 week at 24 hour intervals.[7 days (168 hours) after start of treatment therapy.<br><br>By the primary timepoint, we will have a total of 7 daily measures of the primary outcome representing total sexual activity over a 1 week period.]

Secondary Outcome Measures

Name	Time	Method
Time to first report sexual intercourse in the last 24 hours -yes.[Secondary timepoint will measure time elapse from start of treatment to first sexual activity.<br><br>This is a measure of how soon participants re-engage in sexual activity following start of treatment.]